Effect of Bone-anchored Protraction on Maxillary Growth in the Young Child
NCT ID: NCT02711111
Last Updated: 2016-03-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2016-04-30
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Skeletal Anchorage Versus Conventional Tooth-Borne Face Mask Therapy Following the Alt-RAMEC Protocol
NCT07279662
Comparison Between Protraction Facemask and Upper Braces for Underbite Correction in Growing Children
NCT06759896
Evaluation of Different Anchorage-supported Appliances and Expansion Procedures for Face Mask Treatment
NCT06244563
Efficacy of RME and Facemask Therapy for Class III Malocclusion
NCT07053683
Comparison of Two Miniscrew Anchored Maxillary Protraction Protocols
NCT03712007
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Class III malocclusions may originate in a retrognathic maxilla, a prognathic mandible or both. Young patients with class III malocclusion and maxillary hypoplasia are conventionally treated with a protraction facemask or reverse twin block appliance in order to stimulate forward growth of the upper jaw. This treatment option is often inducing unwanted side effects including mesial migration of the teeth in the upper jaw and clockwise rotation of the mandible. Because skeletal effects are often difficult to achieve with this approach, more pronounced class III malocclusions cannot be addressed by face mask therapy. These children cannot be treated during childhood and end up in major orthognathic surgery at full-grown age.
To be able to treat also the more pronounced class III malocclusion and to minimize dentoalveolar compensations new treatment methods were developed which uses skeletal anchorage. In maxillary deficiency cases it's common to have the deficiency anteroposteriorly as well as transversely. Opening of the midpalatal suture by rapid expansion can correct the transverse hypoplasia and may produce more anterior movement of the maxilla. The proposed technique enables to start skeletal anchorage treatment at an earlier age, which also has the potential of more growth modification during treatment.
Objective:
To compare a new technique of skeletal traction with incorporation of maxillary expansion to conventional treatment protocols.
Study design:
This is a RCT
Study population:
Healthy human volunteers (7- 14 yrs old) with class III malocclusion due to maxillary deficiency.
Intervention:
The intervention consists of the application of a mentoplate (anchored with screws to the bone) in the lower jaw and two screws in the upper jaw (palate). Expansion in the upper jaw is achieved by a classic Hyrax appliance, connected to these screws. Anterior movement of the maxilla is subsequently accomplished by intermaxillary elastic traction to the mentoplate.
Control group (conventional treatment):
Anterior movement of the maxilla accomplished by elastic traction to a face mask
Main study parameters/endpoints:
The main study parameter is the difference in the amount of forward growth of the upper jaw and mid-face (measured with a cone beam CT) compared to the growth that is observed with conventional treatment.
A cone beam CT will be made before the start of traction therapy (baseline) and after 1 year of therapy to evaluate the amount of expansion and forward growth of the maxilla.
One last cone beam CT will be produced at the end of growth, 5 years after start of the orthodontic traction, to evaluate the long-term stability of the obtained advancement.
Other end-points will be patients' satisfaction and complication-rate.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
orthodontic bone anchor
new bone anchor device, which creates anterior traction on the upper jaw. Placed on the chin-region intra-orally.
orthodontic bone anchor
to apply force on the upper jaw (24 / 7) via intra-oral elastics on the bone-anchor
face mask protraction
control group, conventional treatment method. Face mask creates anterior traction on the upper jaw
Face mask
to apply for on the upper jaw (12 - 14 hrs / day) via extra-oral elastics to the face mask
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Face mask
to apply for on the upper jaw (12 - 14 hrs / day) via extra-oral elastics to the face mask
orthodontic bone anchor
to apply force on the upper jaw (24 / 7) via intra-oral elastics on the bone-anchor
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
7 Years
14 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ziekenhuis Oost-Limburg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joeri Meyns
J. Meyns, M.D., D.M.D., oral and maxillofacial Surgery, principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ziekenhuis Oost Limburg
Genk, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Joeri Meyns, M.D., D.M.D.
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Meyns J, Meewis J, Dons F, Schreurs A, Aerts J, Shujaat S, Politis C, Jacobs R. Long-term comparison of maxillary protraction with hybrid hyrax-facemask vs. hybrid hyrax-mentoplate protocols using Alt-RAMEC: a 5-year randomized controlled trial. Eur J Orthod. 2025 Feb 7;47(2):cjaf011. doi: 10.1093/ejo/cjaf011.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MKA Genk
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.